These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 20579720)

  • 1. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine.
    Gagnon R; Primeau MN; Des Roches A; Lemire C; Kagan R; Carr S; Ouakki M; Benoît M; De Serres G;
    J Allergy Clin Immunol; 2010 Aug; 126(2):317-23. PubMed ID: 20579720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada.
    Rouleau I; De Serres G; Skowronski DM; Drolet JP; Lemire C; Toth E; Landry M
    Vaccine; 2014 Jun; 32(28):3480-7. PubMed ID: 24793951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.
    Scheifele DW; Ward BJ; Dionne M; Vanderkooi O; Langley JM; Dobson S; Li Y; Law B; Halperin SA;
    Pediatr Infect Dis J; 2011 May; 30(5):402-7. PubMed ID: 21178654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease.
    Schuler JE; King WJ; Dayneka NL; Rastelli L; Marquis E; Chad Z; Hui C
    Can J Public Health; 2011; 102(3):196-9. PubMed ID: 21714318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on influenza vaccination in patients with egg allergy.
    Gruenberg DA; Shaker MS
    Curr Opin Pediatr; 2011 Oct; 23(5):566-72. PubMed ID: 21881505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
    Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
    Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administering influenza vaccine to egg-allergic persons.
    Kelso JM
    Expert Rev Vaccines; 2014 Aug; 13(8):1049-57. PubMed ID: 24962036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine.
    Rouleau I; De Serres G; Drolet JP; Skowronski DM; Ouakki M; Toth E; Landry M; Ménard S; Gagnon R
    Vaccine; 2013 Dec; 31(50):5989-96. PubMed ID: 24144473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of the H1N1 influenza A vaccine in egg allergic individuals.
    Greenhawt MJ; Chernin AS; Howe L; Li JT; Sanders G
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):387-93. PubMed ID: 21055666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy.
    Esposito S; Gasparini C; Martelli A; Zenga A; Tremolati E; Varin E; Marseglia GL; Fiocchi A; Principi N
    Vaccine; 2008 Aug; 26(36):4664-8. PubMed ID: 18639601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of influenza vaccine administration in egg-allergic patients.
    Chung EY; Huang L; Schneider L
    Pediatrics; 2010 May; 125(5):e1024-30. PubMed ID: 20368312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
    Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P
    Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.
    Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N
    Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination of multidisciplinary resources for vaccination of egg-allergic individuals during an H1N1 (novel) influenza pandemic.
    Pien GC; LeBenger KS; Carotenuto DR; Difilippi M; Scolpino D; Simmons JM; Barrett C; Brenner RW
    Allergy Asthma Proc; 2010; 31(6):507-10. PubMed ID: 20943012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
    Reynales H; Astudillo P; de Vallière S; Hatz C; Schlagenhauf P; Rath B; Velentgas P; Fariña A; Sales-Carmona V; Groth N
    Vaccine; 2012 Oct; 30(45):6436-43. PubMed ID: 22902681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
    Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R
    Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.